Immune Enhancement in Patients With Predicted Severe Acute Necrotizing Pancreatitis: Important Implications for Timing and Early Stratification

Yuying Li,Ping Zhu,Qing Xia,Wei Huang,Robert Sutton

DOI: https://doi.org/10.1097/MPA.0000000000002266

2023-01-01

Pancreas

Abstract:Li, Yuying MSc; Zhu, Ping MSc; Xia, Qing MD; Huang, Wei MD, PhD; Sutton, Robert DPhil, FRCS Author Information

What problem does this paper attempt to address?

Immune enhancement in patients with predicted severe acute necrotising pancreatitis: a multicentre double-blind randomised controlled trial

Lu Ke,Jing Zhou,Wenjian Mao,Tao Chen,Yin Zhu,Xinting Pan,Hong Mei,Vikesh Singh,James Buxbaum,Gordon Doig,Chengjian He,Weili Gu,Weihua Lu,Shumin Tu,Haibin Ni,Guoxiu Zhang,Xiangyang Zhao,Junli Sun,Weiwei Chen,Jingchun Song,Min Shao,Jianfeng Tu,Liang Xia,Wenhua He,Qingyun Zhu,Kang Li,Hongyi Yao,Jingyi Wu,Long Fu,Wendi Jiang,He Zhang,Jiajia Lin,Baiqiang Li,Zhihui Tong,John Windsor,Yuxiu Liu,Weiqin Li,Chinese Acute Pancreatitis Clinical Trials Group (CAPCTG),Mingfeng Huang,Longxiang Cao,Mengjie Lu,Yan Chen,Gang Li,Bo Ye,Fang Shao,Nonghua Lv,Zhenping Chen,Youdong Wan,Miao Chen,Zigui Zhu,Feng Zhou,Bing Xue,Xiaofei Huang,Dandan Zhou,Lening Ren,Dahuan Li,Wei Zhao,Xiaomei Chen,Keke Xin,Qingcheng Xu,Qingbo Zeng,Dongsheng Zhao,Hongguo Yang,Bin Wu,Huaguang Ye,Mingzhi Chen,Yingjie Chen,Mei Yang,Hong Gao,Qiang Li,Lijuan Zhao,Guobing Chen,Yafei Li,Honghai Xia,Dongliang Yang,Shusheng Zhou,Jiyan Lin,Siyao Liu,Donghuang Hong,Songjing Shi,Zuozheng Wang,Weijie Yao,Yi Sun,Kaixiu Qin,Shan Xu,Lei Yu,Feng Guo,Yongjun Lin,Yun Zhou,Qinghai Jiao,Quanxing Feng,Zhiyong Li

DOI: https://doi.org/10.1007/s00134-022-06745-7

Abstract:Purpose: Infected pancreatic necrosis (IPN) is a highly morbid complication of acute necrotising pancreatitis (ANP). Since there is evidence of early-onset immunosuppression in acute pancreatitis, immune enhancement may be a therapeutic option. This trial aimed to evaluate whether early immune-enhancing Thymosin alpha 1 (Tα1) treatment reduces the incidence of IPN in patients with predicted severe ANP. Methods: We conducted a multicentre, double-blind, randomised, placebo-controlled trial involving ANP patients with an Acute Physiology and Chronic Health Evaluation II (APACHE II) score ≥ 8 and a computed tomography (CT) severity score ≥ 5 admitted within 7 days of the advent of symptoms. Enrolled patients were assigned to receive a subcutaneous injection of Tα1 1.6 mg every 12 h for the first 7 days and 1.6 mg once a day for the subsequent 7 days or matching placebos (normal saline). The primary outcome was the development of IPN during the index admission. Results: A total of 508 patients were randomised, of whom 254 were assigned to receive Tα1 and 254 placebo. The vast majority of the participants required admission to the intensive care unit (ICU) (479/508, 94.3%). During the index admission, 40/254(15.7%) patients in the Tα1 group developed IPN compared with 46/254 patients (18.1%) in the placebo group (difference -2.4% [95% CI - 7.4 to 5.1%]; p = 0.48). The results were similar across four predefined subgroups. There was no difference in other major complications, including new-onset organ failure (10.6% vs. 15%), bleeding (6.3% vs. 3.5%), and gastrointestinal fistula (2% vs. 2.4%). Conclusion: The immune-enhancing Tα1 treatment of patients with predicted severe ANP did not reduce the incidence of IPN during the index admission.
Prediction of the Severity of Acute Pancreatitis Using Machine Learning Models.

You Zhou,Fei Han,Xiao-Lei Shi,Jun-Xian Zhang,Guang-Yao Li,Chen-Chen Yuan,Guo-Tao Lu,Liang-Hao Hu,Jia-Jia Pan,Wei-Ming Xiao,Guang-Huai Yao

DOI: https://doi.org/10.1080/00325481.2022.2099193

2022-01-01

Postgraduate Medicine

Abstract:BACKGROUND:Acute pancreatitis (AP) is the most common pancreatic disease. Predicting the severity of AP is critical for making preventive decisions. However, the performance of existing scoring systems in predicting AP severity was not satisfactory. The purpose of this study was to develop predictive models for the severity of AP using machine learning (ML) algorithms and explore the important predictors that affected the prediction results.METHODS:The data of 441 patients in the Department of Gastroenterology in our hospital were analyzed retrospectively. The demographic data, blood routine and blood biochemical indexes, and the CTSI score were collected to develop five different ML predictive models to predict the severity of AP. The performance of the models was evaluated by the area under the receiver operating characteristic curve (AUC). The important predictors were determined by ranking the feature importance of the predictive factors.RESULTS:Compared to other ML models, the extreme gradient boosting model (XGBoost) showed better performance in predicting severe AP, with an AUC of 0.906, an accuracy of 0.902, a sensitivity of 0.700, a specificity of 0.961, and a F1 score of 0.764. Further analysis showed that the CTSI score, ALB, LDH, and NEUT were the important predictors of the severity of AP.CONCLUSION:The results showed that the XGBoost algorithm can accurately predict the severity of AP, which can provide an assistance for the clinicians to identify severe AP at an early stage.
Unraveling the immunological landscape in acute pancreatitis progression to sepsis: insights from a Mendelian randomization study on immune cell traits

Wenbin Liu,Xiaofeng Wang,Shanzhi Zhao,Song Yang,Xiangtao Zheng,Fangchen Gong,Lei Pei,Dan Xu,Ranran Li,Zhitao Yang,Enqiang Mao,Erzhen Chen,Ying Chen

DOI: https://doi.org/10.3389/fimmu.2024.1374787

IF: 7.3

2024-03-28

Frontiers in Immunology

Abstract:Background: Acute pancreatitis (AP) is a severe digestive system disorder with a significant risk of progressing to sepsis, a major cause of mortality. Unraveling the immunological pathways in AP is essential for developing effective treatments, particularly understanding the role of specific immune cell traits in this progression. Methods: Employing a bidirectional two-sample Mendelian Randomization (MR) approach, this study first examined the causal relationship between AP and 731 immune cell traits to identify those significantly associated with AP. Subsequently, we explored the causal associations between 731 immune cell traits and sepsis. The analysis utilized extensive genome-wide association studies (GWAS) summary datasets, with a focus on identifying common immune cell traits with statistically significant causal associations between AP and sepsis. Results: Our investigation identified 44 immune cell traits unidirectionally associated with AP and 36 traits unidirectionally associated with sepsis. Among these, CD127 on CD28 + CD45RA - CD8 + T cells emerged as a common mediator, accounting for 5.296% of the increased risk of sepsis in AP patients. This finding highlights the significant role of specific memory CD8 + T cells in the pathophysiology of AP and its progression to sepsis. Conclusion: This study elucidates the critical role of specific immune cell traits, particularly CD127 hi memory CD8 + T cells, in the progression of AP to sepsis. Our findings provide a foundation for future research into targeted immune-modulatory therapies, potentially improving patient outcomes in AP-related sepsis and offering new insights into the complex immunological dynamics of this condition.

immunology
Early Predictors of Infected Pancreatic Necrosis in Severe Acute Pancreatitis: Implications of Neutrophil to Lymphocyte Ratio, Blood Procalcitonin Concentration, and Modified CT Severity Index

Qing-Yun Zhu,Ruo-Meng Li,Yun-Peng Zhu,Dong-Liang Hao,Yan Liu,Jing Yu,Xue Yang,Yu-Shi Zhang,Tian-Jiao Lin,Xu Yan,Jian-Xin Zuo,Xin-Ting Pan

DOI: https://doi.org/10.1159/000529366

Abstract:Background: Infected pancreatic necrosis (IPN) accounts for 30% mortality in severe acute pancreatitis (SAP). Early prediction of IPN occurrence is critical for prophylactic measures to be taken. This study aimed to evaluate the predicting value for IPN of combined markers at early stages of SAP. Methods: The clinical records of 324 SAP patients admitted within 48 h after disease onset were retrospectively analyzed. As potential predictors, the neutrophil to lymphocyte ratio (NLR), blood procalcitonin (PCT) concentration on the 1st, 4th, and 7th day post admission, as well as modified computerized tomography severity index (MCTSI) on the 5-7th day post admission, were extracted. Correlations between these features with IPN were analyzed using logistic regression, and predictive values were estimated using the receiver operating characteristic curve analyses. Results: NLR, PCT, body mass index, and MCTSI were significantly higher in the IPN group (p < 0.001) compared to the control, among which NLR, PCT, and MCTSI were identified as independent predictors for IPN in logistic regression model. Combination of these parameters yielded significant predicting values with an area under curve of 0.92, sensitivity of 97.2%, and specificity of 77.2% in receiver operating characteristic curve analysis. Conclusion: Combination of NLR, PCT, MCTSI might facilitate the prediction of IPN occurrence in SAP patients.
Effect of Baicalin and Octreotide on the Expression Levels of P‐selectin Protein in Multiple Organs of Rats with Severe Acute Pancreatitis

Xiping Zhang,Guanghua Feng,Jun Jiang,Hua Tian,Li Chen,Yang Cai,Yuemin Shou,Jin Ma,Meili Ma,Feibo Zhu

DOI: https://doi.org/10.1111/j.1440-1746.2009.05902.x

2009-01-01

Journal of Gastroenterology and Hepatology

Abstract:Aim:To investigate the effect of baicalin and octreotide on the expression levels of P-selectin protein in multiple organs of rats with severe acute pancreatitis and explore the underlying mechanism.Methods:Rats were randomly divided into sham-operated, model control, baicalin-treated and octreotide-treated groups. At 3, 6 and 12 h after operation, the mortality rates of rats, the contents of plasma endotoxin as well as serum NO and ET-1, the pathological changes in multiple organs, and the expression levels of P-selectin protein in each group were observed.Results:At 12 h after operation, the mortality rates of rats in treated groups were significantly lower than that in the model control group (P < 0.05), and the pathological severity scores in multiple organs in treated groups were also significantly lower than those in the model control group (P < 0.05). The contents of plasma endotoxin, serum PLA(2) (at 6 and 12 h after operation), ET-1 and NO (at 3 and 12 h after operation) in treated groups were significantly lower than those in the model control group (P < 0.05, P < 0.01 or P < 0.001). In the baicalin-treated group, the expression levels of P-selectin protein in liver (at 3 h after operation), kidney (at 3 and 6 h after operation), pancreas, lung and spleen were significantly lower than those in the model control group (P < 0.01). In the octreotide-treated group, the expression levels of this protein in lung, intestinal mucosa (at 6 and 12 h after operation), lymph nodes (at 3 and 6 h after operation), spleen and thymus were significantly lower than those in the model control group (P < 0.05). Additionally, the products of the staining intensity and positive rate of P-selectin protein in pancreas, spleen (at 3 h after operation), intestinal mucosa (at 6 h after operation), thymus (at 6 h after operation) and lung (at 6 h after operation) in treated groups were significantly lower than those in the model control group (P < 0.05).Conclusion:Both baicalin and octreotide can exert some protective effects on multiple organs and the former is superior to the latter in protecting pancreas. Furthermore, decreasing the expression levels of P-selectin protein in these organs is one of the possible mechanisms.
Immune Status and Inflammatory Response Differ Locally and Systemically in Severe Acute Pancreatitis.

CB Shi,X Zhao,A Lagergren,M Sigvardsson,XD Wang,R Andersson

DOI: https://doi.org/10.1080/00365520500318965

2006-01-01

Scandinavian Journal of Gastroenterology

Abstract:OBJECTIVE:Acute pancreatitis (AP) is an inflammatory disorder that develops a complex cascade of immunological events. The local and systemic immune status and inflammatory response might contribute to the understanding of underlying pathophysiological mechanisms and potential treatment.MATERIAL AND METHODS:Severe AP was induced by intraductal perfusion of 5% sodium taurodeoxycholate in rats. mRNA expression of cytokines and chemokines was determined by reverse transcriptase-polymerase chain reaction (RT-PCR) and NF-kappaB activation was assessed by electrophoretic mobility shift assay in fresh pancreatic acini and circulating monocytes 1, 3, 6 or 9 h after sham operation, induction of AP or N-acetylcysteine (NAC) pretreatment. Flow cytometry was performed on cells obtained from the peripheral blood.RESULTS:An inverse relationship in pancreatic and circulating monocytic NF-kappaB activation was detected 6 and 9 h after induction of AP. NAC further suppressed monocytic NF-kappaB activation induced by AP as seen 9 h after induction of AP. A marked constitutive increase in the expression of IL-6, CINC and MCP-1 was seen in pancreatic acini, whereas no change in mRNA expression of inflammatory mediators was observed in circulating monocytes 6 h after induction of AP. Flow cytometry further confirmed the altered function of circulating monocytes.CONCLUSIONS:The different immune status and inflammatory response in the pancreas and circulating monocytes improve the understanding of the mechanisms by which systemic inflammatory response syndrome (SIRS) and multiple organ dysfunction syndrome (MODS) develop in severe AP. A potential therapeutic approach could be to restore the functional capacity of the immune system in AP. The use of an NF-kappaB inhibitor, preferentially reaching the local inflammatory foci, could be a potential future way of intervention.
Efficacy of immune nutrients in severe acute pancreatitis: A network meta-analysis

Xin Tao,Yurui Yang,Shanshan Xu,Qing Xiong

DOI: https://doi.org/10.1097/md.0000000000035615

IF: 1.6

2024-02-10

Medicine

Abstract:Acute pancreatitis is an inflammatory disease of the exocrine pancreas, usually accompanied by damage or necrosis of the pancreatic parenchyma and peripancreatic tissues. The global incidence of acute pancreatitis has reached 34/100,000, with an increasing trend every year. It also has a high mortality rate, with an annual death rate of 1.16/100,000, higher than chronic pancreatitis. [ 1 , 2 ] Acute pancreatitis is divided into mild, moderate, and severe according to the severity. Approximately 20% of acute pancreatitis cases progress to severe acute pancreatitis, often accompanied by persistent organ failure, a relatively higher Apache II score, and a mortality rate of 36% to 50%. [ 2 , 3 ] Apache II is acute physiology and chronic health evaluation II. It consists of 3 parts: the acute physiology score, the age points, and the chronic health points, and is related to the severity of the disease. [ 4 ]

medicine, general & internal
Early Predictive Factors of Inhospital Mortality in Patients with Severe Acute Pancreatitis

Xin Wang,Zhuang Cui,Jian Zhang,Hechao Li,Dapeng Zhang,Benchun Miao,Yunfeng Cui,Erpeng Zhao,Zhong‐Lian Li,Naiqiang Cui

DOI: https://doi.org/10.1097/mpa.0b013e3181b65dd5

2010-01-01

Pancreas

Abstract:Wang, Xin MD; Cui, Zhuang MD; Zhang, Jian MD; Li, Hechao MD; Zhang, Dapeng MD; Miao, Bin MD; Cui, Yunfeng MD; Zhao, Erpeng MD; Li, Zhonglian MD; Cui, Naiqiang MD, PhD Author Information
Effects of Early Enteral Nutrition on Immune Function of Severe Acute Pancreatitis Patients

Jia-Kui Sun,Xin-Wei Mu,Wei-Qin Li,Zhi-Hui Tong,Jing Li,Shu-Yun Zheng

DOI: https://doi.org/10.3748/wjg.v19.i6.917

IF: 5.374

2013-01-01

World Journal of Gastroenterology

Abstract:AIM:To investigate the effects of early enteral nutrition （EEN） on the immune function and clinical outcome of patients with severe acute pancreatitis （SAP）.METHODS:Patients were randomly allocated to receive EEN or delayed enteral nutrition （DEN）.Enteral nutrition was started within 48 h after admission in EEN group,whereas from the 8 th day in DEN group.All the immunologic parameters and C-reactive protein （CRP） levels were collected on days 1,3,7 and 14 after admission.The clinical outcome variables were also recorded.RESULTS:Sixty SAP patients were enrolled to this study.The CD4+ T-lymphocyte percentage,CD4+/CD8+ ratio,and the CRP levels in EEN group became significantly lower than in DEN group from the 7 th day after admission.In contrast,the immunoglobulin G（IgG） levels and human leukocyte antigen-DR expression in EEN group became significantly higher than in DEN group from the 7 th day after admission.No difference of CD8+ T-lymphocyte percentage,IgM and IgA levels was found between the two groups.The incidences of multiple organ dysfunction syndrome,systemic inflammatory response syndrome,and pancreatic infection as well as the duration of intensive care unit stay were significantly lower in EEN group than in DEN group.However,there was no difference of hospital mortality between the two groups.CONCLUSION:EEN moderates the excessive immune response during the early stage of SAP without leading to subsequent immunosuppression.EEN can improve the clinical outcome,but not decrease the hospital mortality of SAP patients.
The Effect of Immunonutrition in Patients with Acute Pancreatitis: a Systematic Review and Meta‐analysis

J. Zhou,Y. Xue,Y. Liu,X.K. Li,Z.H. Tong,W.Q. Li

DOI: https://doi.org/10.1111/jhn.12816

IF: 3.3

2020-01-01

Journal of Human Nutrition and Dietetics

Abstract:AbstractBackgroundThe effect of immunonutrition is controversial compared to standard supplementation with respect to the management of patients with acute pancreatitis.MethodsAn online literature search on four databases (PubMed, Cochrane, Embase and Web of Science) was performed to identify all of the randomised controlled trials assessing the effects of enteral or parenteral immunonutrition in acute pancreatitis. A fixed or random effects model was chosen using revman, version 5.3 (https://revman.cochrane.org). The count data were analysed using the risk ratio (RR) and 95% confidence interval (CI).ResultsFive hundred and sixty‐eight patients were included via our search in which 14 articles matched our criteria for enrolling the meta‐analysis. Immunonutrition significantly reduced the risk of organ failure (RR = 0.42; 95% CI = 0.26–0.70, P = 0.0008), infectious complications (RR = 0.78; 95% CI = 0.62‐0.99; P = 0.04) and mortality (RR = 0.37; 95% CI = 0.21–0.66; P = 0.006). Length of hospital stay was also shorter in patients who received immunonutrition (mean difference = −1.73 days; 95% CI = −2.36 to −1.10; P < 0.00001). Total interventions of patients were decreased (RR = 0.73; 95% CI = 0.55–0.97; P = 0.03). Body mass index in patients with immunonutrition was reduced more than standard nutrition (mean difference = −2.00; 95% CI = −3.96 to −0.04; P = 0.05).ConclusionsImmunonutrition support such as glutamine and ω‐3 fatty acids is potentially beneficial with respect to improving clinical outcomes in patients with acute pancreatitis.
Association Between Pretreatment Lymphocyte Count and Efficacy of Immune-Enhancing Therapy in Acute Necrotising Pancreatitis: a Post-Hoc Analysis of the Multicentre, Randomised, Placebo-Controlled TRACE Trial.

Lu Ke,Wenjian Mao,Fang Shao,Jing Zhou,Minyi Xu,Tao Chen,Yuxiu Liu,Zhihui Tong,John Windsor,Penglin Ma,Weiqin Li

DOI: https://doi.org/10.1016/j.eclinm.2023.101915

IF: 15.1

2023-01-01

EClinicalMedicine

Abstract:Background Immune-enhancing thymosin alpha 1 (T alpha 1) therapy may reduce infected pancreatic necrosis (IPN) in acute necrotising pancreatitis (ANP). However, the efficacy might be impacted by lymphocyte count due to the pharmacological action of T alpha 1. In this post-hoc analysis, we tested the hypothesis that pre-treatment absolute lymphocyte count (ALC) determines whether patients with ANP benefit from T alpha 1 therapy. Methods A post-hoc analysis of data from a multicentre, double-blind, randomised, placebo-controlled trial testing the efficacy of T alpha 1 therapy in patients with predicted severe ANP was performed. Patients from 16 hospitals of China were randomised to receive a subcutaneous injection of T alpha 1 1.6 mg every 12 h for the frst 7 days and 1.6 mg once a day for the following 7 days or a matching placebo during the same period. Patients who discontinued the T alpha 1 regimen prematurely were excluded. Three subgroup analyses were conducted using the baseline ALC (at randomisation), and the group allocation was maintained as intention-to-treat. The primary outcome was the incidence of IPN 90 days after randomisation. The fitted logistic regression model was applied to identify the range of baseline ALC where T alpha 1 therapy could exert a maximum effect. The original trial is registered with ClinicalTrials.gov, NCT02473406. Findings Between March 18, 2017, and December 10, 2020, a total of 508 patients were randomised in the original trial, and 502 were involved in this analysis, with 248 in the T alpha 1 group and 254 in the placebo group. Across the three subgroups, there was a uniform trend toward more significant treatment effects in patients with higher baseline ALC. Within the subgroup of patients with baseline ALC >= 0.8 x 10 boolean AND 9/L (n = 290), the T alpha 1 therapy significantly reduced the risk of IPN (covariate adjusted risk difference, -0.12; 95% CI, -0.21,-0.02; p = 0.015). Patients with baseline ALC between 0.79 and 2.00 x 10 boolean AND 9/L benefited most from the T alpha 1 therapy in reducing IPN (n = 263). Interpretation This post-hoc analysis found that the efficacy of immune-enhancing T alpha 1 therapy on the incidence of IPN may be associated with pretreatment lymphocyte count in patients with acute necrotising pancreatitis. Funding National Natural Science Foundation of China. 2023;58: 2023
Early infection in patients with severe acute pancreatitis

Gai-qi YAO,Xi ZHU,Shi-ning BO,Ying LIN,Wen-xiong LI

DOI: https://doi.org/10.3760/j.issn:1007-631X.2007.12.004

2007-01-01

Abstract:Objective To investigate predisposing factors for early infection in patients with severe acute pancreatitis.Methods The clinical and laboratory data including age、gender、APACHE Ⅱscore on admission、hemodiastase、mechanical ventilation、blood calcium、mean arterial blood pressure、blood glucose、 alanine aminotransferase、aspartate aminotransferase、total bilirubin、necrosis of the pancreas、hypoxemia、 entero-functional disturbance、etiological factor、serum albumin、serum creatinine、urea nitrogen and haematocrit were analyzed by multiple linear regression in relation with the infection incidence in the 86 SAP patients hospitalized from Jan 2002 to Mar 2007.Results The fasting time、hiliary panereatitis、 hypoxemia、necrosis of pancreas、entero-functional disturbance、serum creatinine、urea nitrogen and haematocrit were positively correlated with the incidence of pancreatic infection(all P<0.05)and serum albumin was negatively correlated with the incidence of pancreatic infection(P<0.01). Conclusions Fasting time、biliary pancreatitis、hypoxemia、necrosis of pancreas、entero-functional disturbance、operation、serum creatinine、urea nitrogen and haematocrit may be the important factors in the pancreatic infection.
Immune markers of severe acute pancreatitis

Peter J Lee,Georgios I Papachristou,Cate Speake,Adam Lacy-Hulbert

DOI: https://doi.org/10.1097/MOG.0000000000001053

2024-09-01

Abstract:Purpose of review: Acute pancreatitis is a common acute inflammatory disorder of the pancreas, and its incidence has been increasing worldwide. Approximately 10% of acute pancreatitis progresses to severe acute pancreatitis (SAP), which carries significant morbidity and mortality. Disordered immune response to pancreatic injury is regarded as a key event that mediates systemic injury in SAP. In this article, we review recent developments in immune biomarkers of SAP and future directions for research. Recent findings: Given the importance of the NLRP3-inflammasome pathway in mediating systemic inflammatory response syndrome and systemic injury, recent studies have investigated associations of SAP with systemic levels of activators of NLRP3, such as the damage associated molecular patterns (DAMPs) for the first time in human SAP. For example, circulating levels of histones, mitochondrial DNAs, and cell free DNAs have been associated with SAP. A panel of mechanistically relevant immune markers (e.g., panel of Angiopoeitin-2, hepatocyte growth factor, interleukin-8 (IL-8), resistin and sTNF-α R1) carried higher predictive accuracies than existing clinical scores and individual immune markers. Of the cytokines with established relevance to SAP pathogenesis, phase 2 trials of immunotherapies, including tumor necrosis factor (TNF)-alpha inhibition and stimulation of IL-10 production, are underway to determine if altering the immunologic response can reduce the severity of acute pancreatitis (AP). Summary: Circulating systemic levels of various DAMPs and a panel of immune markers that possibly reflect activities of different pathways that drive SAP appear promising as predictive biomarkers for SAP. But larger multicenter studies are needed for external validation. Studies investigating immune cellular pathways driving SAP using immunophenotyping techniques are scarce. Interdisciplinary efforts are also needed to bring some of the promising biomarkers to the bedside for validation and testing for clinical utility. Studies investigating the role of and characterization of altered gut-lymph and gut-microbiota in severe AP are needed.
Identification of novel immune-related targets mediating disease progression in acute pancreatitis

Qiang Liu,Lingyun Li,Dongchao Xu,Jianpeng Zhu,Zhicheng Huang,Jianfeng Yang,Sile Cheng,Ye Gu,Liyun Zheng,Xiaofeng Zhang,Hongzhang Shen

DOI: https://doi.org/10.3389/fcimb.2022.1052466

IF: 6.073

2022-12-15

Frontiers in Cellular and Infection Microbiology

Abstract:Introduction: Acute pancreatitis (AP) is an inflammatory disease with very poor outcomes. However, the order of induction and coordinated interactions of systemic inflammatory response syndrome (SIRS) and compensatory anti-inflammatory response syndrome (CARS) and the potential mechanisms in AP are still unclear. Methods: An integrative analysis was performed based on transcripts of blood from patients with different severity levels of AP (GSE194331), as well as impaired lung (GSE151572), liver (GSE151927) and pancreas (GSE65146) samples from an AP experimental model to identify inflammatory signals and immune response-associated susceptibility genes. An AP animal model was established in wild-type (WT) mice and Tlr2-deficient mice by repeated intraperitoneal injection of cerulein. Serum lipase and amylase, pancreas impairment and neutrophil infiltration were evaluated to assess the effects of Tlr2 in vivo . Results: The numbers of anti-inflammatory response-related cells, such as M2 macrophages ( P = 3.2 × 10 –3 ), were increased with worsening AP progression, while the numbers of pro-inflammatory response-related cells, such as neutrophils ( P = 3.0 × 10 –8 ), also increased. Then, 10 immune-related AP susceptibility genes (SOSC3, ITGAM, CAMP, FPR1, IL1R1, TLR2, S100A8/9, HK3 and MMP9) were identified. Finally, compared with WT mice, Tlr2-deficient mice exhibited not only significantly reduced serum lipase and amylase levels after cerulein induction but also alleviated pancreatic inflammation and neutrophil accumulation. Discussion: In summary, we discovered SIRS and CARS were stimulated in parallel, not activated consecutively. In addition, among the novel susceptibility genes, TLR2 might be a novel therapeutic target that mediates dysregulation of inflammatory responses during AP progression.

immunology,microbiology
Characteristics and risk factors for extrapancreatic infection in patients with moderate or severe acute pancreatitis

Tongtian Ni,Yi Wen,Bing Zhao,Ning Ning,Erzhen Chen,Enqiang Mao,Weijun Zhou

DOI: https://doi.org/10.1016/j.heliyon.2023.e13131

IF: 3.776

2023-01-20

Heliyon

Abstract:Background: How to detect acute pancreatitis (AP) complicated with infection early and how to arrange the treatment time are still the main problems in the world. There are few reports on the potential relationship between extrapancreatic infections and AP. The purpose of this article was to investigate the characteristics, influencing factors and prognosis of extrapancreatic infection in AP patients with modified Marshall score ≥2 on admission. Materials and methods: We retrospectively analyzed AP admitted to emergency intensive care unit of Ruijin hospital within 72 h of onset from September 2019 to December 2021. In addition to the patients' baseline data, sites of infection and microorganisms outside the pancreas were collected. Microbial cultures were used to identify infections of the respiratory tract, blood, abdominal cavity, biliary tract, urinary tract and clostridium difficile in feces. Results: 144 patients with AP were included, of which extrapancreatic infection accounted for 40.28%. C-reactive protein, procalcitonin, blood urea nitrogen, serum creatinine, oxygenation index, modified Marshall score, BISAP score and APACHE II score were significantly increased in the extrapancreatic infection group. The risk factors of extrapancreatic infection included blood urea nitrogen, Modified Marshall score and duration of mechanical ventilation. The positive rates of pathogenic bacteria in sputum culture, blood culture, ascites culture and bile culture were significantly higher than those in the 1-3 days after admission. The infection begins to worsen as early as 4-7 days after the onset of symptoms. Extrapancreatic infection is associated with pancreatic necrosis, the rate of laparotomy, length of hospital stay and in-hospital mortality. Conclusion: Our research has confirmed the need to prevent and monitor extrapancreatic infection in the early stage.
Dynamic profiling of immune microenvironment during pancreatic cancer development suggests early intervention and combination strategy of immunotherapy

Jiaqi Yang,Qi Zhang,Junli Wang,Yu Lou,Zhengtao Hong,Shumei Wei,Ke Sun,Jianing Wang,Yiwen Chen,Jianpeng Sheng,Wei Su,Xueli Bai,Tingbo Liang

DOI: https://doi.org/10.1016/j.ebiom.2022.103958

IF: 11.205

2022-04-01

EBioMedicine

Abstract:SummaryBackgroundPancreatic ductal adenocarcinoma (PDAC) has little response to immune checkpoint inhibitors. An in-depth understanding of the immune microenvironment from a comprehensive and dynamic perspective is critical to generate effective therapeutic strategies for PDAC.MethodsUsing mass cytometry and immunohistochemistry, we explored the dynamic changes of tumor-infiltrating immune cells during the development of PDAC in a genetically engineered mouse model (KrasG12D/+; Trp53R172H/+; Pdx1-cre) and human specimens. PD-L1−/− mice were crossed with KrasG12D/+; TgfβR2flox/flox; Ptf1a-cre mice to achieve early depletion of PD-L1 in pancreatic cancer. Combination therapy of Arginase-1 (Arg-1) inhibitor and anti-PD-1 mAb was validated in syngeneic mouse models.FindingsTwo different stages of immunosuppression with unique features were observed in both mouse model and human specimens. Early stage of immunosuppression featured highly abundant Tregs during acinar-to-ductal metaplasia, despite of a prominent and continuous presence of effector lymphocytes. The differentiation/activation branch of Ly-6C+ monocytes changed from a BST2+/MHC-II+ phenotype to an Arg-1+ phenotype over time during PDAC development. The late stage of immunosuppression thus featured the presence of a large number of myeloid suppressive cells together with a significant reduction of effector lymphocytes. Removal of PD-L1 from the beginning efficiently triggered anti-tumor immunity and significantly prolonged survival in PDAC-developing mice. Targeting Arg1+ macrophages with an Arg-1 inhibitor synergized with anti-PD-1 immunotherapy and led to PDAC-specific immune memory.InterpretationBy demonstrating the coevolution of histopathology and immunology in PDAC, this study highlights the necessity and value of early intervention and combinational approach in leveraging immunotherapy to treat pancreatic cancer.FundingA full list of funding bodies that contributed to this study can be found in the Acknowledgements section.

medicine, research & experimental
Machine Learning Improves Prediction of Severity and Outcomes of Acute Pancreatitis: a Prospective Multi-Center Cohort Study

Jia-Ning Li,Dong Mu,Shi-Cheng Zheng,Wei Tian,Zuo-Yan Wu,Jie Meng,Rui-Feng Wang,Tian-Lei Zheng,Yue-Lun Zhang,John Windsor,Guo-Tao Lu,Dong Wu

DOI: https://doi.org/10.1007/s11427-022-2333-8

IF: 3.977

2023-01-01

Pancreatology

Abstract:>Dear Editor,Acute pancreatitis(AP) is a common acute pancreatic disease of variable severity and outcomes(Mederos et al.,2021). According to systemic and local complications, patients can be classified into severe, moderately severe, and mild AP(Banks et al., 2013). About 20% of AP patients develop severe acute pancreatitis(SAP, with persistent organ failures) of whom 20%–50% die.
Combination of NK and Other Immune Markers at Early Phase Stratify the Risk of Sepsis Patients: A Retrospective Study

Zihan Hu,Danjiang Dong,Fei Peng,Xing Zhou,Qin Sun,Hui Chen,Wei Chang,Qin Gu,Jianfeng Xie,Yi Yang

DOI: https://doi.org/10.2147/jir.s426828

IF: 4.5

2023-01-01

Journal of Inflammation Research

Abstract:Purpose:Immune dysfunction plays a pivotal role in sepsis pathogenesis. Previous studies have revealed the crucial role of T cells and human leukocyte antigen-DR (HLA-DR) in sepsis. However, the function of natural killer (NK) cells remains unclear. This study aimed to investigate whether NK cells are associated with sepsis prognosis. In addition, we aimed to explore the interrelation and influence between NK and other immunological features in patients with sepsis.Patients and Methods:This retrospective, observational study included patients with sepsis from two hospitals in mainland China. The clinical characteristics and immune results during the early phase were collected. Patients were classified according to the level of immune cells to analyze the relationship between immunological features and 28-day mortality.Results:A total of 984 patients were included in this study. Non-survivors were older and had lower levels of lymphocytes, monocytes, NK cells, HLA-DR, and T cells. Patients were classified into eight groups according to their levels of NK cells, HLA-DR, and T cells. Only patients with decreased NK and T cell counts showed a significant increase in 28-day mortality. An increase in CD8+ T cells was correlated with the alleviation of 28-day mortality only among patients with high NK cell levels.Conclusion:This study provides novel insights into the association between NK cells and 28-day mortality as well as the interrelation between NK cells and other immune cells in sepsis. The relationship between CD8+ T cells and 28-day mortality in sepsis is dependent on NK cell count.
From pancreas to lungs: The role of immune cells in severe acute pancreatitis and acute lung injury

Qi Liu,Xiaomei Zhu,Shubin Guo

DOI: https://doi.org/10.1002/iid3.1351

2024-07-20

Immunity Inflammation and Disease

Abstract:The article attentively demonstrates how immune cells serve as a "bridge" between severe acute pancreatitis and acute lung damage. The immunologic properties of immune cells may result in better patient outcomes and the creation of novel immunotherapies. Immune cells can also be used to predict the course of a disease, giving doctors a strong starting point. Background Severe acute pancreatitis (SAP) is a potentially lethal inflammatory pancreatitis condition that is usually linked to multiple organ failure. When it comes to SAP, the lung is the main organ that is frequently involved. Many SAP patients experience respiratory failure following an acute lung injury (ALI). Clinicians provide insufficient care for compounded ALI since the underlying pathophysiology is unknown. The mortality rate of SAP patients is severely impacted by it. Objective The study aims to provide insight into immune cells, specifically their roles and modifications during SAP and ALI, through a comprehensive literature review. The emphasis is on immune cells as a therapeutic approach for treating SAP and ALI. Findings Immune cells play an important role in the complicated pathophysiology ofSAP and ALI by maintaining the right balance of pro‐ and anti‐inflammatory responses. Immunomodulatory drugs now in the market have low thepeutic efficacy because they selectively target one immune cell while ignoring immune cell interactions. Accurate management of dysregulated immune responses is necessary. A critical initial step is precisely characterizing the activity of the immune cells during SAP and ALI. Conclusion Given the increasing incidence of SAP, immunotherapy is emerging as a potential treatment option for these patients. Interactions among immune cells improve our understanding of the intricacy of concurrent ALI in SAP patients. Acquiring expertise in these domains will stimulate the development of innovative immunomodulation therapies that will improve the outlook for patients with SAP and ALI.

immunology
Identification and Validation of Immune Molecular Subtypes in Pancreatic Ductal Adenocarcinoma: Implications for Prognosis and Immunotherapy

Ruiyu Li,Yangzhige He,Hui Zhang,Jing Wang,Xiaoding Liu,Hangqi Liu,Huanwen Wu,Zhiyong Liang

DOI: https://doi.org/10.3389/fimmu.2021.690056

2021-07-15

Abstract:Background: Pancreatic ductal adenocarcinoma (PDAC) remains treatment refractory. Immunotherapy has achieved success in the treatment of multiple malignancies. However, the efficacy of immunotherapy in PDAC is limited by a lack of promising biomarkers. In this research, we aimed to identify robust immune molecular subtypes of PDAC to facilitate prognosis prediction and patient selection for immunotherapy. Methods: A training cohort of 149 PDAC samples from The Cancer Genome Atlas (TCGA) with mRNA expression data was analyzed. By means of non-negative matrix factorization (NMF), we virtually dissected the immune-related signals from bulk gene expression data. Detailed immunogenomic and survival analyses of the immune molecular subtypes were conducted to determine their biological and clinical relevance. Validation was performed in five independent datasets on a total of 615 samples. Results: Approximately 31% of PDAC samples (46/149) had higher immune cell infiltration, more active immune cytolytic activity, higher activation of the interferon pathway, a higher tumor mutational burden (TMB), and fewer copy number alterations (CNAs) than the other samples (all P < 0.001). This new molecular subtype was named Immune Class, which served as an independent favorable prognostic factor for overall survival (hazard ratio, 0.56; 95% confidence interval, 0.33-0.97). Immune Class in cooperation with previously reported tumor and stroma classifications had a cumulative effect on PDAC prognostic stratification. Moreover, programmed cell death-1 (PD-1) inhibitors showed potential efficacy for Immune Class (P = 0.04). The robustness of our immune molecular subtypes was further verified in the validation cohort. Conclusions: By capturing immune-related signals in the PDAC tumor microenvironment, we reveal a novel molecular subtype, Immune Class. Immune Class serves as an independent favorable prognostic factor for overall survival in PDAC patients.

Immune Enhancement in Patients With Predicted Severe Acute Necrotizing Pancreatitis: Important Implications for Timing and Early Stratification

Immune enhancement in patients with predicted severe acute necrotising pancreatitis: a multicentre double-blind randomised controlled trial

Prediction of the Severity of Acute Pancreatitis Using Machine Learning Models.

Unraveling the immunological landscape in acute pancreatitis progression to sepsis: insights from a Mendelian randomization study on immune cell traits

Early Predictors of Infected Pancreatic Necrosis in Severe Acute Pancreatitis: Implications of Neutrophil to Lymphocyte Ratio, Blood Procalcitonin Concentration, and Modified CT Severity Index

Effect of Baicalin and Octreotide on the Expression Levels of P‐selectin Protein in Multiple Organs of Rats with Severe Acute Pancreatitis

Immune Status and Inflammatory Response Differ Locally and Systemically in Severe Acute Pancreatitis.

Efficacy of immune nutrients in severe acute pancreatitis: A network meta-analysis

Early Predictive Factors of Inhospital Mortality in Patients with Severe Acute Pancreatitis

Effects of Early Enteral Nutrition on Immune Function of Severe Acute Pancreatitis Patients

The Effect of Immunonutrition in Patients with Acute Pancreatitis: a Systematic Review and Meta‐analysis

Association Between Pretreatment Lymphocyte Count and Efficacy of Immune-Enhancing Therapy in Acute Necrotising Pancreatitis: a Post-Hoc Analysis of the Multicentre, Randomised, Placebo-Controlled TRACE Trial.

Early infection in patients with severe acute pancreatitis

Immune markers of severe acute pancreatitis

Identification of novel immune-related targets mediating disease progression in acute pancreatitis

Characteristics and risk factors for extrapancreatic infection in patients with moderate or severe acute pancreatitis

Dynamic profiling of immune microenvironment during pancreatic cancer development suggests early intervention and combination strategy of immunotherapy

Machine Learning Improves Prediction of Severity and Outcomes of Acute Pancreatitis: a Prospective Multi-Center Cohort Study

Combination of NK and Other Immune Markers at Early Phase Stratify the Risk of Sepsis Patients: A Retrospective Study

From pancreas to lungs: The role of immune cells in severe acute pancreatitis and acute lung injury

Identification and Validation of Immune Molecular Subtypes in Pancreatic Ductal Adenocarcinoma: Implications for Prognosis and Immunotherapy